Header image

Advances in the management of acute myeloid leukaemia

Track 1
Tuesday, April 30, 2024
2:15 PM - 3:45 PM
Hall 1B


The treatment landscape of acute myeloid leukaemia (AML) continues to evolve. In this session new treatment options for patients with newly diagnosed and relapsed AML will be discussed including the pivotal role of clinical trials and the development of a UK AML Registry.


Agenda Item Image
Prof. Steve Knapper
Consultant Haematologist
Cardiff University

Optimising chemotherapy options in fit adults with acute myeloid leukaemia

Agenda Item Image
Dr. Mike Dennis
Consultant Haematologist
The Christie NHS Foundation Trust

Expanding treatment options in unfit adults with AML

Agenda Item Image
Dr Pramila Krishnamurthy
Consultant Haematologist
King's College Hospital

Management of Relapsed AML

Agenda Item Image
Dr. Priyanka Mehta
Consultant Haematologist
University Hospitals of Bristol and Weston NHS Trust

The development of a UK AML registry


Agenda Item Image
Charles Craddock
Professor Of Haemato-oncology
Warwick Clinical Trials Unit